<DOC>
	<DOC>NCT00003565</DOC>
	<brief_summary>RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to compare the effectiveness of docetaxel in treating Caucasian and African American patients who have solid tumors.</brief_summary>
	<brief_title>Docetaxel in Treating Patients With Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES: - Compare the population pharmacokinetics of docetaxel in Caucasians and African American patients with solid tumors. - Compare the pharmacodynamic effect of a single dose of docetaxel in relation to hematological toxicity in these patient populations. - Determine the CYP3A4 genotype and P-glycoprotein (P-gp) expression and their relationship to docetaxel clearance in these patient populations. OUTLINE: Patients receive docetaxel IV over 1 hour on day 1. Patients may receive additional courses beginning 21 days after the first docetaxel dose at the discretion of the physician.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS: Histologically proven unresectable solid tumors (e.g., lung, breast, head and neck, bladder) Clinically suitable for treatment with single agent docetaxel Caucasian (at least 2 generations originating in any of the original peoples of Europe, North Africa, or the Middle East) OR African American (at least 2 generations originating in any of the black racial groups of Africa) PATIENT CHARACTERISTICS: Age: 18 and over Performance status: 02 Hematopoietic: Granulocyte count at least 1,500/mm3 Platelet count at least 100,000/mm3 Hepatic: Bilirubin no greater than upper limit of normal (ULN) AST no greater than 1.5 times ULN AND Alkaline phosphatase no greater than 2.5 times ULN Renal: BUN no greater than 1.5 times ULN Creatinine no greater 1.5 times ULN Other: Not pregnant or nursing Fertile patients must use effective contraception PRIOR CONCURRENT THERAPY: Biologic therapy: No prior bone marrow transplantation Chemotherapy: No prior docetaxel Prior paclitaxel allowed 1 or 2 prior chemotherapy regimens allowed At least 4 weeks since prior chemotherapy (6 weeks for nitrosoureas or mitomycin) No other concurrent chemotherapy Endocrine therapy: No concurrent hormones for disease related conditions Concurrent steroids for adrenal failure allowed Radiotherapy: At least 2 weeks since prior radiotherapy Palliative radiotherapy allowed except whole brain irradiation for CNS disease Surgery: Not specified Other: At least 48 hours since prior or concurrent ethanol (CYP3A enzyme inducer) or grapefruit juice (CYP3A enzyme inhibitor) At least 7 days since prior or concurrent CYP450 inducing drugs: Antiseizure medications: phenobarbital, phenytoin, carbamazepine, or lamotrigine AntiTB therapy: rifampin, isoniazid, or sulfinpyrazone At least 7 days since prior or concurrent CYP450 3A inhibiting drugs: Macrolides: erythromycin, clarithromycin, azithromycin, or roxithromycin Azoles: ketoconazole, fluconazole, or itraconazole Other antibiotics: metronidazole or chloramphenicol AntiHIV drugs: ritonavir, indinavir, nelfinavir, or delavirdine Immunosuppressive agents: cyclosporine Antidepressant agent: nefazodone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>stage III bladder cancer</keyword>
	<keyword>recurrent bladder cancer</keyword>
	<keyword>stage IV bladder cancer</keyword>
	<keyword>stage IV nasopharyngeal cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>unspecified adult solid tumor, protocol specific</keyword>
	<keyword>untreated metastatic squamous neck cancer with occult primary</keyword>
	<keyword>recurrent metastatic squamous neck cancer with occult primary</keyword>
	<keyword>pulmonary carcinoid tumor</keyword>
	<keyword>stage III squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>stage III basal cell carcinoma of the lip</keyword>
	<keyword>stage III verrucous carcinoma of the oral cavity</keyword>
	<keyword>stage III mucoepidermoid carcinoma of the oral cavity</keyword>
	<keyword>stage III adenoid cystic carcinoma of the oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>stage IV basal cell carcinoma of the lip</keyword>
	<keyword>stage IV verrucous carcinoma of the oral cavity</keyword>
	<keyword>stage IV mucoepidermoid carcinoma of the oral cavity</keyword>
	<keyword>stage IV adenoid cystic carcinoma of the oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>recurrent basal cell carcinoma of the lip</keyword>
	<keyword>recurrent verrucous carcinoma of the oral cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma of the oral cavity</keyword>
	<keyword>recurrent adenoid cystic carcinoma of the oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma of the oropharynx</keyword>
	<keyword>stage III lymphoepithelioma of the oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma of the oropharynx</keyword>
	<keyword>stage IV lymphoepithelioma of the oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma of the oropharynx</keyword>
	<keyword>recurrent lymphoepithelioma of the oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma of the nasopharynx</keyword>
	<keyword>stage III lymphoepithelioma of the nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma of the nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma of the nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma of the nasopharynx</keyword>
	<keyword>recurrent lymphoepithelioma of the nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma of the hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma of the hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma of the hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma of the larynx</keyword>
	<keyword>stage III verrucous carcinoma of the larynx</keyword>
	<keyword>stage IV squamous cell carcinoma of the larynx</keyword>
	<keyword>stage IV verrucous carcinoma of the larynx</keyword>
	<keyword>recurrent squamous cell carcinoma of the larynx</keyword>
	<keyword>recurrent verrucous carcinoma of the larynx</keyword>
	<keyword>stage III squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage III inverted papilloma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage III midline lethal granuloma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage IV inverted papilloma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage IV midline lethal granuloma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>recurrent inverted papilloma of the paranasal sinus and nasal cavity</keyword>
	<keyword>recurrent midline lethal granuloma of the paranasal sinus and nasal cavity</keyword>
	<keyword>recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
</DOC>